Literature DB >> 16724799

Breaking ignorance: the case of the brain.

H Wekerle1.   

Abstract

Immunological self-tolerance is maintained through diverse mechanisms, including deletion of autoreactive immune cells following confrontation with autoantigen in the thymus or in the periphery and active suppression by regulatory cells. A third way to prevent autoimmunity is by hiding self tissues behind a tissue barrier impermeable for circulating immune cells. The latter mechanism has been held responsible for self-tolerance within the nervous tissue. Indeed, the nervous tissues enjoy a conditionally privileged immune status: they are normally unreachable for self-reactive T and B cells, they lack lymphatic drainage, and they are deficient in local antigen-presenting cells. Yet the immune system is by no means fully ignorant of the nervous structures. An ever-growing number of brain specific autoantigens is expressed within the thymus, which ensures an early confrontation with the unfolding T cell repertoire, and there is evidence that B cells also contact CNS-like structures outside of the brain. Then pathological processes such as neurodegeneration commonly lift the brain's immune privilege, shifting the local milieus from immune-hostile to immune-friendly. Finally, brain-reactive T cells, which abound in the healthy immune repertoire, but remain innocuous throughout life, can be activated and gain access to their target tissues. On their way, they take an ordered migration through peripheral lymphoid tissues and blood circulation, and undergo a profound reprogramming of their gene expression profile, which renders them fit to enter the nervous system and to interact with local cellule elements.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16724799     DOI: 10.1007/3-540-29714-6_2

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  15 in total

1.  Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology.

Authors:  Daniel Larocque; Nicholas S R Sanderson; Josée Bergeron; James F Curtin; Joe Girton; Mia Wibowo; Niyati Bondale; Kurt M Kroeger; Jieping Yang; Liliana M Lacayo; Kevin C Reyes; Catherine Farrokhi; Robert N Pechnick; Maria G Castro; Pedro R Lowenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

2.  Comparative gene expression analysis in mouse models for multiple sclerosis, Alzheimer's disease and stroke for identifying commonly regulated and disease-specific gene changes.

Authors:  Vivian Tseveleki; Renee Rubio; Sotiris-Spyros Vamvakas; Joseph White; Era Taoufik; Edwige Petit; John Quackenbush; Lesley Probert
Journal:  Genomics       Date:  2010-05-07       Impact factor: 5.736

Review 3.  CNS immune privilege: hiding in plain sight.

Authors:  Monica J Carson; Jonathan M Doose; Benoit Melchior; Christoph D Schmid; Corinne C Ploix
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

4.  Immunity to a self-derived, channel-forming peptide in the respiratory tract.

Authors:  Frederik W van Ginkel; Takeo Iwamoto; Bruce D Schultz; John M Tomich
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

5.  The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses.

Authors:  Tammy Kielian; Mohsin Md Syed; Shuliang Liu; Nirmal K Phulwani; Napoleon Phillips; Gail Wagoner; Paul D Drew; Nilufer Esen
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 6.  Multifaceted interactions between adaptive immunity and the central nervous system.

Authors:  Jonathan Kipnis
Journal:  Science       Date:  2016-08-19       Impact factor: 47.728

Review 7.  Towards a 'systems'-level understanding of the nervous system and its disorders.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Trends Neurosci       Date:  2013-08-27       Impact factor: 13.837

8.  Good news-bad news: the Yin and Yang of immune privilege in the eye.

Authors:  John V Forrester; Heping Xu
Journal:  Front Immunol       Date:  2012-11-27       Impact factor: 7.561

9.  Immune privilege of the CNS is not the consequence of limited antigen sampling.

Authors:  Melissa G Harris; Paul Hulseberg; Changying Ling; Jozsef Karman; Benjamin D Clarkson; Jeffrey S Harding; Mengxue Zhang; Adam Sandor; Kelsey Christensen; Andras Nagy; Matyas Sandor; Zsuzsanna Fabry
Journal:  Sci Rep       Date:  2014-03-21       Impact factor: 4.379

Review 10.  Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease.

Authors:  Agata Matejuk; Arthur A Vandenbark; Halina Offner
Journal:  Front Neurol       Date:  2021-05-31       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.